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Pin1 and Par14 Peptidyl
Prolyl Isomerase Inhibitors
Block Cell Proliferation
domain structure are conserved among almost all eu-
karyotes, including Saccharomyces cerevisiae (Ess1)
[3–5], Schizosaccharomyces pombe (Pin1) [6], Candida
albicans (Ess1) [7], Drosophila melanogaster (Dodo) [8],
Neurospora crassa (Ssp1) [9], and mouse (Pin1) [10] and
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[13, 14]. Pin1 binds specifically to pSer/pThr-Pro se-Salk Institute
La Jolla, California 92037 quences via its WW domain and isomerizes pSer/Thr-
Pro bonds. Pin1 PPIase activity can alter protein confor-
mation in a phosphorylation-dependent manner and/or
promote protein dephosphorylation [15–19].Summary
The human protein Pin1 was identified through a two-
hybrid screen as a protein that interacts with A. nidulansDisruption of the parvulin family peptidyl prolyl isom-
NIMA. Although originally believed to be a cell cycleerase (PPIase) Pin1 gene delays reentry into the cell
regulator, it is now known that Pin1 functions in manycycle when quiescent primary mouse embryo fibro-
cellular processes through its ability to bind to andblasts are stimulated with serum. Since Pin1 regulates
promote phosphorylation-dependent isomerization ofcell cycle progression, a Pin1 inhibitor would be ex-
pSer/pThr-Pro motifs. Pin1 interacts with many of thepected to block cell proliferation. To identify such in-
MPM-2 antigens in mitotic lysates, including Cdc25Chibitors, we screened a chemical compound library
[15, 16], Wee1 [16], and Myt1 [17]. Pin1 can also catalyzefor molecules that inhibited human Pin1 PPIase activity
a conformational change in phosphorylated Cdc25 [18]in vitro. We found a set of compounds that inhibited
and stimulate dephosphorylation of Cdc25 by PP2A [19].Pin1 PPIase activity in vitro with low M IC50s and
Pin1 can either inhibit or stimulate the activity of phos-inhibited the growth of several cancer lines. Among
phorylated Cdc25C, depending on which sites are phos-the inhibitors, PiB, diethyl-1,3,6,8-tetrahydro-1,3,6,8-
phorylated [16, 18]. Pin1 might act in an analogous fash-tetraoxobenzo[lmn][3,8] phenanthroline-2,7-diacetate
ion as a phosphorylation-specific chaperone for otherethyl 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]
pSer/pThr-Pro-containing mitotic phosphoproteins, ei-phenanthroline-(2H,7H)-diacetate, had the least non-
ther promoting dephosphorylation or a conformationalspecific toxicity. These results suggest that Pin1 inhib-
change, and thereby play a general role in mitotic pro-itors could be used as a novel type of anticancer drug
gression.that acts by blocking cell cycle progression.
In addition to functions in cell cycle control and prolif-
eration, Pin1 is involved in other biological processes.
Introduction Pin1 interacts with phosphorylated tau protein in the
brain and can restore its activity to promote microtubule
Peptidyl prolyl cis-trans isomerases (PPIase) catalyze assembly in vitro [20]. The Drosophila homolog of Pin1,
the cis-trans isomerization of prolyl peptide bonds, and dodo, is required for proper dorsoventral patterning of
PPIase activity is required for a variety of functions in- the follicular epithelium during oogenesis through its
cluding the assembly, folding, and transport of cellular ability to bind to and promote ubiquitin-mediated degra-
proteins. PPIases belong to one of three families, the dation of the CF2 transcription factor following its phos-
cyclophilins, FK506 binding proteins (FKBPs), and par- phorylation by ERK MAP kinase [21]. Pin1 physically
vulins. Two kinds of bacterial parvulin homolog have interacts with phosphorylated NFAT and prevents de-
been identified in human and mouse cells, Pin1 and phosphorylation of the NFAT transcription factor, which
Pin4/Par14 [1, 2]. The prokaryotic parvulins and mam- is required for T cell activation [22]. Pin1 also regulates
malian Par14 consist of only a PPIase domain. Pin1 also turnover and subcellular localization of -catenin by in-
belongs to the parvulin family but in addition to the hibiting its interaction with APC [23]. Recently, Pin1 has
C-terminal PPIase domain, it has a WW domain at its N been found to be overexpressed in breast cancer and
terminus. PPIases with this type of WW-PPIase double- to increase the expression of cyclin D1 as a result of its
ability to bind to c-Jun phosphorylated at the Ser63/73-
Pro motifs in its transactivation domain and thereby*Correspondence: uchidat@idac.tohoku.ac.jp
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stimulate cyclin D1 promoter activity [24]. Pin1 can also may be upregulated and rescue cell growth. In order
to examine whether the lack of Pin1 led to significantincrease the stability and nuclear localization of cyclin
D1 through direct binding to pThr286-Pro [25]. We exam- changes in gene expression, we investigated whether
there were genes differentially expressed in wild-typeined the expression level of Pin1 in 65 clinical samples
with oral squamous cell carcinoma by immunohisto- and Pin1/ MEF using a DNA microarray containing
9448 mouse cDNA clones. The threshold for a significantchemical staining and showed that Pin1 level correlates
with cyclin D1 level [26], which suggests that Pin1 is difference in the microarray hits was set at 1.7. None of
the 9448 genes showed a dramatic change in expressionrelated to oncogenesis of oral squamous cell carcinoma
as well as breast cancer. in the Pin1/ MEF compared to wild-type (Figure 1A).
There were 33 up- and 66 downregulated genes inIn addition to its effects on the function of specific
transcription factors, Pin1 also has more general roles Pin1/ MEF compared to Pin1/ MEF. Figure 1A lists
some of the genes that showed the greatest differencesin transcription. Pin1 binds the phosphorylated CTD of
the largest subunit of RNA polymerase II [14, 27] and in expression. The p21 and p15 Cdk inhibitors and cyclin
G were the most upregulated genes (2- to 3-fold) (Figureactivates basal reporter gene transcription [28]. Ess1
also interacts with the phosphorylated CTD [29], and 1A). The results of quantitative RT-PCR analysis of these
mRNAs coincided with the microarray analysis data (Fig-the ptf1 temperature-sensitive ESS1 allele has a defect
in pre-mRNA 3 end processing [30], suggesting a gen- ure 1A). Expression of insulin-like growth factor (IGF)-2
and cyclin D1 was downregulated in Pin1/ MEF; theeral role in transcription. Multicopy suppressor analysis
of temperature-sensitive ess1 mutants has revealed that ratios were 3.0 and 1.7, respectively. A correlation be-
tween Pin1 levels and cyclin D1 expression was pre-Ess1 plays a role in general transcription/chromatin re-
modeling [31] and in gene silencing via the Sin3p-Rpd3p viously reported by Wulf et al. [24]. However, considering
that Pin1 has been reported to be involved in transcrip-histone deacetylase [32]. Pin1 also plays a role in inhibi-
tion of endocytic membrane transport during mitosis tional regulation, the differences in gene expression be-
tween Pin1/ and wild-type MEF were not as significant[33]. These observations suggest that Pin1/Ess1 might
play an indirect role in cell cycle control either through as we expected. Moreover, Pin1/ MEF had an identical
cell cycle profile compared to Pin1/ MEF (Figure 1B).effects on transcription or on the activity of proteins
required in a general housekeeping sense for growth In Pin1/ MEF, another parvulin family PPIase, hPar14,
was upregulated about 3-fold (Figure 1A). The cyclophi-and cell cycle progression. Thus, the diverse functions
of Pin1/Ess1 in cell proliferation appear to be a result lin C expression was not increased in Pin1/ MEF. We
have not examined the expression levels of variousof its interaction with multiple phosphoproteins.
Although Ess1 has been reported to be essential for types of cyclophilins, but Pin1/ MEF and Pin1/ MEF
did not show different susceptibilities against cyclospo-mitotic progression in S. cerevisiae, C. albicans [7], and
in certain human tumor cells [1, 34], deletion of the Dro- rin A treatment (data not shown). When the level of Par14
was examined by Western blotting, the Par14 level insophila Pin1/Ess1 homolog, dodo [8], fission yeast [6],
and the mouse homolog, Pin1 [10], results in viable or- Pin1/ cells was about 2-fold higher than in Pin1/
MEF (Figure 1C). The results suggested that Par14 mayganisms, albeit with detectable phenotypes. This sug-
gests that these organisms either have additional Pin1 in part replace Pin1 function, and consequently we de-
cided to develop inhibitors for both Pin1 and Par14.family genes, or else that they have PPIases that have
overlapping functions with Pin1/Ess1. This idea would
be consistent with the finding that pin1 budding and
Screening for Pin1 Inhibitorsfission yeast cells are more sensitive than wild-type cells
The most suitable peptide for Pin1 screening would beto cyclosporin A (CsA), which inhibits cyclophilin PPIase
a peptide containing a pSer/pThr-Pro motif, for exampleactivity [5, 6]. We identified a second mammalian par-
WFYpSPR (Kcat/Km: 20,160/mM s), but the peptide Ala-vulin family PPIase, Par14. Although Par14 lacks the
Glu-Pro-Phe (Kcat/Km: 3410/mM s) is good enough tobasic pocket needed for selection of phospho-Ser/Thr-
be used as a substrate for Pin1 PPIase assays [35].Pro substrates, Par14 may substitute for Pin1 in a man-
Moreover, this peptide is also a relatively good substratener similar to cyclophilin PPIases in yeast.
for Par14 compared to other peptides we examinedIn this manuscript, we identified a series of Pin1 and
(Kcat/Km: 620/mM s) [2], meaning that it could also bePar14 PPIase inhibitors and used them to show that
used to screen for Par14 inhibitors. We assayed Pin1Pin1 is important for cell cycle progression. Moreover,
PPIase using AEPF as the substrate. Although the reac-these inhibitors inhibited the growth of cancer cells ex-
tion was very fast and the background was high, it waspressing Pin1 and could potentially be developed into
possible to assay Pin1 PPIase in this manner (Figurenovel antifungal agents and anticancer drugs effective
2A). The method proved suitable for measurement ofagainst some kinds of tumors.
kinetic parameters, such as the peptide Km (Figure 2B).
Using this method, we screened Pin1 PPIase inhibitors
among 1000 chemically synthesized compounds. ThisResults
library mainly consisted of the chemicals synthesized
randomly, but it contained chemicals with double-ringExpression analysis of Pin1/ MEF
The Pin1/ mouse embryo fibroblasts (MEF) grow a structures, like juglone, which is a known Pin1 inhibitor,
and chemicals developed as potential anticancer andlittle slower than the wild-type MEF, but the difference is
not that marked [10]. We speculated that other PPIases, antifungal drugs. Compounds with anticancer cell activ-
ity did not exhibit strong inhibitory activities against can-such as the parvulin family PPIase Par14 or cyclophilins,
Pin1 Inhibitors Cause Cell Cycle Arrest
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Figure 1. Expression Analysis of Pin1/
MEF
(A) List of relevant genes upregulated in
Pin1/ MEF as determined by microarray
and real-time PCR analysis. Poly (A) RNA
samples prepared from the cultured MEF
were analyzed by DNA array (GEM Microar-
ray, Incyte Genomics). The wild-type and
Pin1/ RNAs were labeled with CY3 and
CY5, respectively, and hybridized to 9448
unique mouse cDNA clones. Quantitative
PCR of p21, cyclin G, and Par14 was per-
formed using the iCycler iQ Detection System
(Bio-Rad) and interaction dye SYBR Green.
(B) FACS analysis of Pin1/ and Pin1/
MEF. MEFs were suspended in a solution
containing 50g propidium iodide/ml in 0.1%
sodium citrate and 0.1% Triton X-100 and
analyzed by FACS using the CellQuest pro-
gram (Becton Dickinson).
(C) Western blot analysis of Pin1 and Par14
in Pin1/ and Pin1/ MEF. The proteins (30
g/lane) prepared from cancer cell lines and
MEF were analyzed by SDS-PAGE and elec-
troblotting onto a nitrocellulose membrane.
The membrane was incubated with the 1/500-
fold diluted primary antibody (rabbit anti-Pin1 and anti-Par14) and then with the 1/1000 secondary antibody (horseradish peroxidase-conjugated
goat anti-rabbit IgG). The membrane was soaked in the solution of ECL Western blotting detection reagents and exposed to X-ray film.
didate target proteins, such as topoisomerases I and
II, and we speculated that some of them might exert
anticancer activity through Pin1 inhibition. We screened
the compounds showing inhibition of Pin1 PPIase activ-
ity and roughly estimated the IC50 of them. Among
these, we found a few relatively potent Pin1 inhibitors:
PiA (2,7-dimethylbenzo[lmn][3,8]phenanthroline-1,3,6,8
(2H,7H)-tetrone) (IC50, 2.0 M) and PiB (diethyl-1,3,6,8-
tetrahydro-1,3,6,8-tetraoxobenzo[lmn][3,8] phenanthro-
line-2,7-diacetate) (IC50, 1.5 M) (Figure 3). We synthe-
sized a series of compounds based on these structures
(Figure 3). Among them, PiJ (diethyl-1,3,8,10-tetrahydro-
1,3,8,10-tetraoxoanthra[2,1,9-def:6,5,10-def]diisoquin-
oline-2,9-diacetate) inhibited Pin1 PPIase activity almost
as strongly as PiB, with IC50s of about 1.5 M. PiB and
PiJ inhibited Par14 as potently as Pin1, with IC50s of
1.0 M. Because Pin1 recognizes pSer or pThr in its
targets, a phosphate mimic group might enhance inhibi-
tor potency, although charged chemicals do not pass
through cell membranes readily. However, derivatives
of PiB with alkyl chains terminated with free COOH or
COOCF3 groups that have negative charge, such as PiC,
PiD, and PiE, were no more potent as Pin1 inhibitors in
the in vitro assay. The COOEt groups on PiB may be
deesterified in the cell, generating a negative charge.
Several of the inhibitors have symmetrical structures
Figure 2. Pin1 PPIase Assay
(e.g., PiB), which in principle would allow them to bind
(A) Pin1 PPIase assay. The assay was carried out measuring MCA
in either orientation and might increase potency.fluorescence. Sixty-five microliters of assay buffer (50 mM HEPES,
The binding of the inhibitors to the PPIase domains100 mM NaCl, pH 7.0), 0–4 l of Pin1 solution (11 mg/ml), and 10
of Pin1 [36] and Par14 [37, 38] was examined with thel chymotrypsin (60 mg/ml in 0.001N HCl) were mixed immediately,
then 5 l of the substrate solution, Suc-Ala-Glu-Pro-Phe-MCA, 100 molecular modeling. Docking simulations made using
g/ml in trifluoroethanol containing 480 mM LiCl, was added. The DOCK 4.0 [39] suggested that PiJ and PiB can bind to
reaction was performed for 0–120 s and stopped with 100 l of the active centers of Pin1 (Figures 4A–4C) and Par14
acetic acid/methanol (1:1) followed by measurement of the MCA
(Figures 4D–4F), potentially interacting with or maskingfluorescence (Ex/Em, 365 nm/460 nm) using a fluorescence microti-
active site residues. Figure 4 shows models of PiB andter plate reader.
PiJ bound to Pin1 and Par14 predicted by GOLD version(B) The Km of Pin1 was determined, and the screening conditions
were established based on this Km value (120 M). 1.2, an automated ligand-docking program [40, 41].
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Figure 3. Structures of Pin1 Inhibitors
A known inhibitor, juglone, and the derivatives of the inhibitors we identified. PiA and B (IC50s, about 2 and 1.5 uM, respectively) and the
derivatives were originally synthesized as inhibitors of topoisomerase I, but they did not exhibit such activities. All inhibitors consisted of a
double-ring structure like juglone.
Judging from the docking scores (Figure 4G), these com- rized in Figure 5. Pin1 expression levels differed between
the various cancer cell lines, whereas Par14 expressionpounds can bind to both of Pin1 and Par14 with compa-
levels were similar in all the lines. Cells with a low levelrable affinities. They are docked into the substrate bind-
Pin1, such as HLE and HepG2 cells, were less sensitiveing pocket and make close contacts with catalytic and
to inhibitor treatment than cells expressing high levelssubstrate-recognition residues of the proteins (Figure
of Pin1, such as HSC2, HCT116, and SKOV3 cells. The4G). These suggest that PiB and PiJ may inhibit the
effects of PiB on the growth of wild-type and Pin1/PPIase activities of Pin1 and Par14 in a competitive
MEFs were also examined. PiB inhibited proliferation ofmanner by masking their substrate binding sites, which
wild-type MEF (IC50, 1 M), whereas the same con-is consistent with the observations made in the surface
centration did not inhibit the growth of Pin1/ MEFsplasmon resonance analysis. Since the major compo-
(Figure 6). The proliferation of Pin1/ MEF (B6 geneticnents of the docking scores are contributed by van der
background) reexpressing Pin1 following infection withWaals interactions, the aromatic rings of the compounds
an adenovirus vector was inhibited by PiB at a similarare probably important for binding, making hydrophobic
concentration to that required to inhibit growth ofinteractions with the proteins. In addition, H of Arg69
Pin1/ MEF (Figure 6). The results suggest that one ofand H of His157 of Pin1 and the backbone amide hydro-
the targets of PiB is Pin1 and that inhibition of Pin1 isgen (HN) of Lys75 form hydrogen bonds with oxygen
apparently important for the antiproliferative activity ofatoms of PiB, and H and HN of Gln131 and H of Ser154
PiB. However, this does not rule out the possibility thatof Pin1 form hydrogen bonds with oxygen atoms of PiJ.
PiB may have other targets in addition to Pin1. For exam-Among these, H of Ser154 and H of His157 of Pin1
ple, Par14 is potentially another target of PiB (Figure 4).are suggested to be directly involved in the catalytic
This idea is supported by the finding that siRNA deple-reaction [36]. Therefore, oxygen atoms of the com-
tion of Par14 inhibits the growth of Pin1/ MEF but notpounds may be also important for specific binding to
Pin1/ MEF reexpressing Pin1 (data not shown). Thethe proteins.
results suggest that other PPIases, including Par14, can
substitute for Pin1, and the expression level of such
Effects of Pin1 Inhibitors on Cell Proliferation proteins may influence the susceptibility of different
To determine whether the Pin1 inhibitors reduced cell cells to PiB inhibition.
growth, their effects on the proliferation of a series of To determine whether PiB caused an arrest at a spe-
human cancer cell lines was tested. These inhibitors cific cell cycle phase, Pin1/ MEF cells infected with
had antiproliferative activity against a variety of cancer adenovirus vector or vector containing Pin1 cDNA were
synchronized in G1 by serum starvation and then stimu-cell lines. The IC50s for several cancer lines are summa-
Pin1 Inhibitors Cause Cell Cycle Arrest
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Figure 4. Molecular Modeling of Pin1 Inhibitors and Par14 Inhibitors
Crystal structure of Pin1 (A) and docking models of PiB (C) and PiJ (D) to Pin1. NMR structure of Par14 (D) and docking models of PiB (E)
and PiJ (F) to Par14. In (A) and (D), the backbone structures are shown by ribbon representations. The side chains of catalytic and basic and
hydrophobic substrate-recognition residues are shown by stick models and are colored yellow, blue, and cyan, respectively. Note that Par14
does not have the basic substrate-recognition residues [37], and there are thus no blue residues in (D). In (B), (C), (E), and (F), the surfaces
of Pin1 and Par14 are shown and are colored with the residue colors used in (A) and (D). The compounds are represented by stick models
where hydrogen, carbon, nitrogen, and oxygen atoms are colored white, green, blue, and red, respectively. The docking models were obtained
as follows. The coordinates of Pin1 [36] and Par14 [37] were obtained from the Protein Data Bank (http://www.rcsb.org/pdb) (the identification
codes are 1PIN and 1FJD, respectively). As for Pin1, only the PPIase domain (residues 45–163) was used in the calculation, and hydrogen
atoms were attached using the Biopolymer module of the InsightII software (Accelrys Inc.). The protonation states of histidine residues in the
active sites were modified based on the model of catalytic mechanism [36], where His59 (His42) and His157 (His123) of Pin1 (Par14) are
protonated at N	 and both of N	 and N, respectively. The models of PiB and PiJ were prepared using the Sybyl software (Tripos Inc.). The
position of C
 of the substrate proline bound to Pin1 was used to define the search area. The protein atoms within 20 A˚ from this point were
used in the docking calculation. As for Par14, corresponding point was calculated from superposition of C
 atoms of Pin1 onto those of Par14.
The docking calculations were performed using GOLD version 1.2 with the standard default settings [40, 41]. Ten independent runs were
carried out for each pair of ligand and protein, and the structure with the best score was adopted as the “docking model”.
lated with serum to enter the cell cycle in the presence Given the ability of Pin1 to bind to and isomerize pSer/
Thr-Pro motifs, this led to the suggestion that Pin1 regu-of 1 M PiB. FACS analysis showed that the treated
MEF did not arrest at a specific cell cycle phase (data lates the G2/M transition in yeast and vertebrate cells by
binding mitotic phase phosphoproteins, such as Cdc25,not shown). Likewise, HCT116 cells did not arrest at
specific cell cycle phase. The fraction of cells in S phase, Wee1, Nek2, Cdc27, and topoisomerase IIa, and isom-
however, was increased a little (Figure 7A). HCT116 cells erizing the Ser/Thr-Pro peptide bond at sites phosphory-
treated with 1 M PiB for 48 hr showed decreased ex- lated by mitotic proline-directed kinases such as cyclin
pression of cyclins D1 and B1 (Figure 7B). In contrast, B/Cdc2 [16, 35]. We created mice lacking Pin1 by gene
the levels of cyclins E and A were relatively unaffected disruption and showed that Pin1/ mice are viable,
(Figure 7B). indicating that Pin1 is not essential for cell proliferation
[10, 25]. However, Pin1/ embryonic fibroblasts derived
from these mice grow slower than normal MEF, andDiscussion
upon serum starvation they enter an irreversible G0 state
[10]. These results suggest that there is a redundantDepletion of Pin1 from HeLa cells by antisense RNA
function that can partially compensate for Pin1 in grow-expression and the depletion of Ess1 (yeast Pin1) from
ing cells but cannot rescue Pin1/ MEF from G0 arrest.budding yeast by gene disruption both cause mitotic
arrest and in HeLa cells. This leads to apoptosis [1, 34]. With regard to what other PPIases might compensate
Chemistry & Biology
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Figure 5. Effects of Pin1 Inhibitors on Cancer Cell Proliferation
(A) Results of anticell proliferation (MTT) assay. Cancer lines HSC2, HSC4, HCT116, Huh7, OVK2, SKOV3, HepG2, and HLE were treated with
PiA derivatives (PiA-PiM). The IC50 for growth inhibition by these compounds for each cell line is listed.
(B) Expression levels of Pin1 and Par14 in these cancer lines used for the antiproliferation assay were detected by Western blot analysis (30
g/lane).
for the lack of Pin1, the most obvious possibility is Par14. [2], and although the active site lacks the basic pocket
present in Pin1 [37] that is needed for recognition ofUnder normal circumstances, their distinct peptide sub-
strates preferences [2, 35], three-dimensional structures phosphorylated substrates [36] and dictates Pin1’s
more restricted substrate specificity, one might antici-[36–38], and subcellular localizations [1, 42] suggest that
Pin1 and Par14 PPIases have different biological roles pate that Par14 will act on Pin1 targets, albeit less effi-
ciently, particularly because Par14 lacks the WW domainin cells. However, the Par14 substrate profile is broad
Figure 6. Effects of Pin1 Inhibitors on Pin1/
MEFs
The effects of Pin1 inhibitors on cell prolifera-
tion were examined with MTT assay. Three
thousand cells/well of the Pin1/ MEF pre-
pared from the original Pin1/ mice and
modified MEF prepared from Pin1/ mice
backcrossed onto the B6 genetic back-
ground and infected with adenovirus expres-
sion vector containing no insert or full-length
Pin1 cDNA were plated in a 96-well plate and
treated with PiB or juglone (0.15–5 M).
Pin1 Inhibitors Cause Cell Cycle Arrest
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Figure 7. Effects of Pin1 Inhibitor on the Cell
Cycle
(A) HCT116 cells synchronized at G0 by se-
rum starvation were treated with 1 M PiB
for 48 hr, stained with propidium iodide, and
analyzed by FACS. The percentages of the
subpopulations of the cells are summarized
in the table.
(B) The levels of the indicated cell cycle pro-
teins in HCT116 cells treated with 1 M PiB
for 24 and 48 hr were analyzed by Western
blotting. Forty micrograms of each cell lysate
was loaded per lane followed by electropho-
resis. The blot membranes were reacted with
mouse monoclonal antibodies against cy-
clin D1, cyclin E, cyclin A, cyclin B, CDK2,
CDC25B, and 
-tubulin and then incubated
with horseradish peroxidase-conjugated anti-
mouse IgG antibody. ECL Western blotting
detection reagents (Amersham, Arlington
Heights, IL) were used according to the man-
ufacturer’s recommendations.
that allows Pin1 to bind to pSer/Thr-Pro-containing mo- not bind DNA and so did not exhibit inhibitory activities
toward candidate target proteins such as topoisomer-tifs. Cyclophilins also have a relatively broad substrate
specificity [35], and cyclophilin PPIase activity compen- ase I (data not shown). We synthesized several PiA/B
derivatives and examined their IC50s. Among the deriva-sates for the depletion of Ess1 in budding and fission
yeasts [5, 6] even though Ess1 and cyclophilin belong tives, PiB and PiJ were the most potent inhibitors of
Pin1 PPIase activity (Figure 3). PiB and PiJ interferedto different PPIase subfamilies. It seems unlikely that
FKBP family PPIase will substitute for Pin1 because with the binding of the tetrapeptide AEPF to Pin1 (Figure
4A). PiB and PiJ were competitive inhibitors of Pin1FKBPs require a hydrophobic residue preceding the tar-
get proline. activity, whereas juglone was not. A model of the mecha-
nism of enzymatic inhibition by PiB and PiJ is shown inTo learn more about the phenotypes of Pin1/ MEF,
we looked for genes that are differentially expressed Figure 4B. The molecular modeling results show that
the compounds can potentially bind both Pin1 and Par14between Pin1/ and Pin1/ MEF. Among the 10,000
genes examined, no genes were found to be strongly at the active site (Figure 4), consistent with their ability
to inhibit both PPIases.upregulated in the Pin1/ MEF. RNAs for several cell-
cycle-related proteins, including p21 and cyclin G, which PiB and PiJ were the most potent inhibitors of prolifer-
ation of several cancer lines (Figure 5A). Cancer linesare p53-regulated genes [43, 44], were slightly upregu-
lated. The most differentially expressed gene in the expressing a low amount of Pin1 tended to be more
sensitive to treatment with these inhibitors (Figure 5B).Pin1/ MEF was Par14; Par14 RNA was increased
about 3-fold (Figure 1A), and Par14 protein level was Par14 was expressed in all of the lines we examined,
but there was no correlation between the Par14 level andalso increased in Pin1/ MEF (Figure 1C). This provides
further support for the idea that elevated Par14 might the sensitivity to the inhibitors. These results support the
idea that Pin1 is the critical target for these inhibitors,compensate for the lack of Pin1. On this basis, we rea-
soned that a small molecule able to inhibit both Pin1 even though there are other potential target molecules
such as Par14. The fact that the inhibitors did not blockand Par14 might block cell proliferation by causing cell
cycle arrest. Pin1/ MEF proliferation at a dose that was sufficient
to inhibit growth of wild-type MEF (Figure 6) also sug-We developed a screening method to isolate Pin1/
Par14 PPIase inhibitors. The cis to trans isomerization gests that Pin1 is a major target for PiB and PiJ. Cyclo-
philin C PPIase activity was only weakly inhibited by PiBof the Ser-Pro peptide bond proceeds fast, so we per-
formed the assay at 4C. The peptide substrate we chose and PiJ (IC50s 10 M), making it unlikely that PiB and
PiJ act on cyclophilins. FKBP PPIase activity was notwas AEPF, because it is a peptide substrate that can
be utilized by both Pin1 [11] and Par14 [2]. The reliability inhibited at this dose (data not shown), consistent with
the ability of cyclophilin 18 but not FKBP12 to act onof this assay method was confirmed by enzyme kinetic
analysis (Figure 2). Our chemical library screen identified AEPF [35].
To investigate how PiB and PiJ inhibit cell prolifera-PiA and PiB, originally synthesized as a derivative of
PiA, as the most potent inhibitors with IC50s of 2 M tion, we analyzed cell cycle events in the sensitive colon
carcinoma line HCT116. Treatment with PiB increasedand 1.5 M, respectively. For comparison, juglone, the
only previously reported Pin1 inhibitor, which is irrevers- the population of cells in S phase at 48 hr after cells
were stimulated to enter the cell cycle following serumible and rather nonspecific [45, 46], has an IC50 of 5 M.
PiA and PiB have double-ring structures like juglone, but starvation, but there was not a specific cell cycle arrest
(Figure 7A). The level of cyclins D1 and B1 was reducedotherwise their overall structures are completely differ-
ent from the juglone quinone (Figure 3). PiA and PiB did in PiB-treated HCT116 cells, whereas the levels of
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cyclins E and A, CDK2, and Cdc25B were largely unaf- fied and were used to show that Pin1 is important
for cell cycle progression. Moreover, these inhibitorsfected (Figure 7B). The very low level of cyclin B1 will
preclude entry into mitosis, but progression through slowed the growth of cancer cells expressing Pin1 and
thus are promising drug leads that could be developedother phases of the cycle may also be slowed and may
account for the increase in S-phase cells. into novel anticancer drugs or, alternatively, potent
antifungal agents.Our results show that Pin1 is an important regulator
of cell growth and cell cycle progression. Even though
cells lacking Pin1 can cycle normally, presumably be-
Experimental Procedures
cause other PPIases, such as Par14 or cyclophilins, can
carry out Pin1 functions, Pin1-expressing cells rely on MEF Culture
Fetuses (13.5 days old) were obtained from wild-type and Pin1/Pin1 to progress through the cell cycle. This finding is
mice. They were dissected, cut into small pieces, and digested within keeping with recent evidence that the proliferation of
trypsin-EDTA. The mouse embryonic fibroblasts (MEF) obtained incancer cells often remains dependent on functions that
this manner were seeded onto a 150 mm culture dish and grown ininitiated their transformation, even though other growth-
DMEM containing 10% fetal bovine serum for two passages. Then,
stimulatory pathways are in principle available to them. cells at 60% confluence were cultured in DMEM containing 10% FCS
In this sense, Pin1-expressing cells are “addicted” to for 3 days. The MEF were replated and harvested for experimental
analysis. The cell cycle distributions of the Pin1/ and Pin1/ MEFPin1, whereas Pin1-deficient cells have “adapted” to
were checked by FACS.doing without Pin1 function [47]. In this regard, it is
interesting to note that Pin1 is overexpressed in a subset
of tumor types and cancer cell lines [24, 26], and these Microarray and Quantitative RT-PCR Analyses
cancers may be susceptible to treatment with Pin1 inhib- Total RNA was prepared from the cultured MEF by extraction with
acid phenol-guanidine-thiocyanate-chloroform, and poly (A)mRNAitors.
was purified from the total RNA using oligo-(dT) cellulose chroma-In summary, we have identified inhibitors for Pin1/
tography. The poly (A) mRNAs (OD260/OD280 1.9) were analyzedPar14 PPIases that inhibit cell proliferation. Pin1 inhibi-
by DNA array (GEM Microarray, Incyte Genomics, Palo Alto, CA).tors of this type could be useful as novel antitumor or
The wild-type and Pin1/ RNAs were labeled with CY3 and CY5,
antifungal drugs. respectively, and hybridized to 9448 unique mouse cDNA clones
from Incyte Genomics. Quantitative PCR was performed using the
iCycler iQ Detection System (Bio-Rad, Richmond, CA) and interac-
tion dye SYBR Green. PCR was performed with the following prim-Significance
ers: p21, 5-CACAGGCGGTTATGAAATTCACCC-3, 5-CAGAGCCC
AGCTGGAGAAGAAGGG-3; cyclin G, 5-GTCTAGATGTCAGCCAAAThe phosphorylation of proteins is a vital biological
GGT-3, 5-ATCAAATCAGTGCCGCCAGT-3; and Par14, 5-GAGTGsignal in cells, critical for processes such as signal
ACAGTGCTGACAAGAAGGC-3, 5-ACCGGTGGGTCTGTAAACACA
transduction, cell cycle progression, and apoptosis. It GGC-3. The PCR conditions were 3 min at 95C, followed by 40
is well documented that the addition of a phosphate cycles of 30 s at 95C, 30 s at 55C, and 1 min at 72C. The amounts
of the products at each step were monitored in real time.group can cause a protein to assume a different bio-
logical role from its unphosphorylated form. However,
what is not understood is the structural basis for the
Screening for Pin1 PPIase Inhibitors
observed functional changes as a result of phosphory- Assay was carried out measuring the MCA fluorescence using Suc-
lation. Peptidyl prolyl cis-trans isomerase (PPIase) cat- Ala-Glu-Pro-Phe-MCA as substrate. The following reaction was per-
formed in the cold room in 96-well microtiter dishes. One microliteralyzes the cis-trans isomerization of prolyl peptide
compounds in DMSO (our own chemical library), 65 l of assaybonds, and PPIase activity is required for the assem-
buffer (50 mM HEPES, 100 mM NaCl, pH 7.0), 10 l of Pin1 solutionbly, folding, and transport of cellular proteins. Pin1 is
(11 g/ml), and 10 l chymotrypsin (60 mg/ml in 0.001N HCl) werea PPIase from the parvulin family that may be particu-
mixed immediately, then 5 l of the substrate solution, Suc-Ala-Glu-
larly important for cell signaling because, in addition Pro-Phe-MCA (Japan Peptide Institute Co., Osaka; 100 g/ml in
to its PPIase domain, it has a WW domain at its N trifluoroethanol containing 480 mM LiCl), was added. The reaction
was performed for 20 s and stopped with 100 l of acetic acidterminus that recognizes and interacts with phospho-
(100%)/methanol (1:1) followed by measurement of the MCA fluores-serine (pSer) or phosphothreonine (pThr)-proline mo-
cence (Ex/Em, 365 nm/460 nm) using a fluorescence microtiter platetifs in several proteins. Specifically, Pin1 binds to pSer/
reader (1420 Multilabel Counter, Wallac Co.).pThr-Pro sequences and isomerizes pSer/Thr-Pro
bonds, altering the protein conformation in a phos-
phorylation-dependent manner and/or promoting pro- MTT Assay
Three thousand cells per well of the Pin1/ MEF prepared from thetein dephosphorylation. This strongly supports a role
original Pin1/ mice [5] and modified MEF prepared from Pin1/for Pin1 as an integral component of the change in
mice backcrossed onto the B6 genetic background and infectedfunction of phosphorylated proteins. In mice, a knock-
with adenovirus expression vector containing no insert or full-length
out of the Pin1 gene resulted in viable offspring, albeit Pin1 cDNA (kindly provided by Han-Kuei Huang) or several different
with detectable phenotypes, suggesting that mice cancer lines were plated in a 96-well plate (Becton Dickinson, Lin-
coln Park, NJ), and a variety of inhibitors were added to the cells.have additional Pin1 genes or PPIases with overlap-
After the cells were incubated for 48 hr, 50l of a 3 mg/ml solution ofping functions. A second mammalian parvulin family
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)PPIase, Par14, was identified. Although it lacks the
(Sigma, St. Louis, MO) was added. The cells were incubated withbasic pocket needed for substrate selection, Par14
MTT for 6 hr at 37C, after which 50 l of a 25% (w/v) SDS solution
may still substitute for Pin1. To investigate the roles with a pH of 2 was added. The plates were incubated overnight to
of these proteins, we established a screen for Pin1 dissolve the formazan crystals, and then the absorption at 540 nm
was measured with a microplate reader (Bio-Rad, model 3550).and Par14 inhibitors. A series of inhibitors were identi-
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Western Blotting 6. Huang, H.K., Forsburg, S.L., John, U.P., O’Connell, M.J., and
Hunter, T. (2001). Isolation and characterization of the Pin1/The cancer cell lines and MEF were lysed in RIPA buffer (10 mM
Tris-HCl, pH 7.5, 300 mM NaCl, 0.1% SDS, 1% Triton X-100, 5 mM Ess1p homologue in Schizosaccharomyces pombe. J. Cell Sci.
114, 3779–3788.EDTA, and 1% sodium deoxycholate) in the presence of protease
inhibitors. Sample buffer containing 0.2% SDS and 0.6% 2-mercap- 7. Devasahayam, G., Chaturvedi, V., and Hanes, S.D. (2002). The
Ess1 prolyl isomerase is required for growth and morphogenetictoethanol was added to 30 g of each lysate; the samples were
boiled for 10 min, then analyzed by SDS-PAGE and electroblotting switching in Candida albicans. Genetics 160, 37–48.
8. Maleszka, R., Hanes, S.D., Hackett, R.L., de Couet, H.G., andonto a nitrocellulose membrane. The membrane was soaked in
blocking solution (1 TBS, 0.05% Tween 20, 3% nonfat dried milk) Miklos, G.L. (1996). The Drosophila melanogaster dodo (dod)
gene, conserved in humans, is functionally interchangeable withfor 1 hr and incubated with the primary antibody (rabbit anti-full-
length Pin1 protein and anti-full-length Par14 protein antibodies the ESS1 cell division gene of Saccharomyces cerevisiae. Proc.
Natl. Acad. Sci. USA 93, 447–451.[our preparation]) or mouse monoclonal antibodies against cyclin
A, cyclin B, cyclin E, and CDK2 (BD Transduction Labs., Lexington, 9. Kops, O., Eckerskorn, C., Hottenrott, S., Fischer, G., Mi, H., and
Tropschug, M. (1998). Ssp1, a site-specific parvulin homologKY), cyclin D1 (Oncogene Research Products, Boston, MA), and

-tubulin (Sigma, St. Louis, MO) for 15 hr at 4C. Then the membrane from Neurospora crassa active in protein folding. J. Biol. Chem.
273, 31971–31976.was washed three times with TBST (1 TBS, 0.05% Tween 20)
and incubated with secondary antibody (horseradish peroxidase- 10. Fujimori, F., Takahashi, K., Uchida, C., and Uchida, T. (1999).
Mice lacking Pin1 develop normally, but are defective in enteringconjugated goat anti-rabbit or mouse IgG [Molecular Probes Inc.,
Eugene, OR]) for 1 hr. All the antibodies were diluted to 1:500. ECL cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun.
265, 658–663.Western blotting detection reagents (Amersham, Arlington Heights,
IL) were used according to the manufacturer’s recommendations. 11. Sudol, M. (1996). The WW module competes with the SH3 do-
main? Trends Biochem. Sci. 21, 161–163.
12. Sudol, M., and Hunter, T. (2000). New wrinkles for an old domain.FACS Analysis
Cell 103, 1001–1004.HCT116 cells and MEF cells infected with adenovirus vector or the
13. Lu, P.J., Zhou, X.Z., Shen, M., and Lu, K.P. (1999). Function ofvector expressing Pin1 cDNA were cultured in DMEM containing
WW domains as phosphoserine- or phosphothreonine-binding0.1% fetal bovine serum for 4 days, then in medium containing 5%
modules. Science 283, 1325–1328.fetal bovine serum with control (0.1% DMSO), 2, 5, and 10 M PiB
14. Verdecia, M.A., Bowman, M.E., Lu, K.P., Hunter, T., and Noel,(0.1% DMSO) for 0, 6, 12, 24, and 48 hr. After observing the cells
J.P. (2000). Structural basis for phosphoserine-proline recogni-under a microscope, the cells were suspended in a solution con-
tion by group IV WW domains. Nat. Struct. Biol. 7, 639–643.taining 50 g propidium iodide/ml in 0.1% sodium citrate and 0.1%
15. Crenshaw, D.G., Yang, J., Means, A.R., and Kornbluth, S. (1998).Triton X-100 and analyzed by FACS using the CellQuest program
The mitotic peptidyl-prolyl isomerase, Pin1, interacts with(Becton Dickinson). To analyze the effect of inhibitors on G1 progres-
Cdc25 and Plx1. EMBO J. 17, 1315–1327.sion, serum-starved HCT116 cells were cultured in the presence of
16. Shen, M., Stukenberg, P.T., Kirschner, M.W., and Lu, K.P. (1998).1 M PiB for 24 hr prior to serum stimulation.
The essential mitotic peptidyl-prolyl isomerase Pin1 binds and
regulates mitosis-specific phosphoproteins. Genes Dev. 12,Supplemental Data
706–720.A supplemental figure that shows how the IC50s of PiB and PiJ
17. Wells, N.J., Watanabe, N., Tokusumi, T., Jiang, W., Verdecia,were determined is available. Please write to chembiol@cell.com
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